Table 2. Enzyme Inhibition, Parasite Viability, and Microsomal Stability of Compound 2a.
IC50 (nM) |
predicted CLb (mL/min/kg) |
||||||||
---|---|---|---|---|---|---|---|---|---|
compd | R | R1 | PfDHODH | HsDHODH | 3D7 | Dd2 | H | M | cLogP |
2a | 4-Me | Me | 39 (n = 4) | >30000 | 10 (n = 4) | 22 (n = 4) | 10 | 66 | 3.9 |
2b | 5-Me | 56 | 87 | 130 | 8 | >72 | 3.9 | ||
2c | 6-Me | 56 | 33 | 74 | 10 | >72 | 3.9 | ||
2d | 7-Me | 609 | 143 | 290 | 6 | >72 | 3.9 | ||
2e | 5-OCF3 | 22 (n = 4) | 7 (n = 4) | 9 (n = 4) | 7 | 43 | 4.7 | ||
2f | 6-OCF3 | 52 (n = 2) | 36 (n = 2) | 53 (n = 2) | 10 | 41 | 4.7 | ||
2g | 5-CF3 | 28 | 20 | 28 | 4 | >72 | 4.3 | ||
2h | 6-CF3 | 92 | 56 | 96 | 8 | 68 | 4.3 | ||
2i | 4-OMe | 162 | 49 | 109 | 4 | >72 | 3.6 | ||
2j | 4-OCHF2 | 44 (n = 6) | 19 (n = 6) | 26 (n = 6) | 4 | 33 | 4.1 | ||
2k | 4-OCH2CHF2 | 28 | 128 | 113 | na | na | 4.2 | ||
2l | 4-F | 34 (n = 2) | 8 (n = 2) | 6 (n = 2) | <4 | 37 | 3.5 | ||
2m | 6-F | 111 | 93 | 113 | <4 | >72 | 3.5 | ||
2n | 4-Cl | 21 (n = 2) | 5 (n = 2) | 6 (n = 2) | <4 | 19 | 4.1 | ||
2o | 5-Cl | 49 | 78 | 102 | na | na | 4.1 | ||
2p | 4-Br | 21 (n = 2) | 4 (n = 2) | 7 (n = 2) | 5 | 26 | 4.3 | ||
2q | 4-CN | 40 (n = 9) | 7 (n = 4) | 10 (n = 4) | <4 | 26 | 2.9 | ||
2r | 4-NMe2 | 181 | 75 | 159 | na | na | 3.9 | ||
2s | 4-F, 6-Me | 32 | 10 | 17 | 12 | >72 | 4.0 | ||
2t | 4-F, 6-Me | H | 17 | 3100 | 4 | 4 | 10 | >72 | 3.5 |
2u | 4-Cl, 6-F | Me | 25 | >30000 | 12 | 13 | 5 | 42 | 4.3 |
2v | 4-Cl, 6-F | H | 35 | 5600 | 8 | 18 | 7 | >72 | 3.8 |
2w | 5-Me, 7-F | H | 95 | 7300 | 36 | 60 | 11 | >72 | 3.5 |
2x | 5-CF3 | H | 19 | 17200 | 12 | 12 | 8 | >72 | 3.8 |
2y | 4-F | H | 62 | 14900 | 17 | 8 | 10 | >72 | 3.0 |
Assay conditions reported in ref (10).
Using microsomes and based on well-stirred model with no correction for microsomal or protein binding.